Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Jay Tuttle, Edit Drescher, Jesus Abraham Simón Campos, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 20, pp. 1853-1862
Closed Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Immune Memory: A New Frontier in Treating Recurrent Inflammatory Skin Diseases
Hang Yin, Jianru Chen, Chunying Li
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Transitional and CD21− PD-1+ B cells are associated with remission in early rheumatoid arthritis
Sarah McGrath, Boel Sundbeck, Katrin Thorarinsdottir, et al.
BMC Rheumatology (2025) Vol. 9, Iss. 1
Open Access
Soluble Co‐Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case‐Control Study
Elvis Hysa, Dario Camellino, Christian Dejaco, et al.
ACR Open Rheumatology (2025) Vol. 7, Iss. 5
Open Access
Comparison of Efficacy and Safety of Single Versus Combination Dmard Therapy in Rheumatoid Arthritis-A Prospective Observational Study
Manjari Singh, M. K. Sharma, Himanshy Rai, et al.
Journal of Pharmacy And Bioallied Sciences (2025) Vol. 17, Iss. Suppl 1, pp. S837-S839
Open Access
The Role of TNF-α in Neuropathic Pain: An Immunotherapeutic Perspective
Mario García‐Domínguez
Life (2025) Vol. 15, Iss. 5, pp. 785-785
Open Access
New molecular targets in the treatment of rheumatoid arthritis
Beth Wallace, Laura G. Cooney, David A. Fox
Current Opinion in Rheumatology (2024) Vol. 36, Iss. 3, pp. 235-240
Closed Access | Times Cited: 3
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression
Jeffrey A. Sparks
Rheumatic Disease Clinics of North America (2024) Vol. 50, Iss. 2, pp. 147-159
Closed Access | Times Cited: 3
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes
Ernesto Maddaloni, Rocco Amendolara, Angela Balena, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 4, pp. 303-318
Closed Access | Times Cited: 3
Therapeutic implications for the PD-1 axis in cerebrovascular injury
James Feghali, Christopher M. Jackson
Neurotherapeutics (2024), pp. e00459-e00459
Open Access | Times Cited: 3
Comprehensive Co-Inhibitory Receptor (Co-IR) Expression on T Cells and Soluble Proteins in Rheumatoid Arthritis
Chin‐Man Wang, Yeong‐Jian Jan Wu, Liyu Huang, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 403-403
Open Access | Times Cited: 2
Identification of critical genes and metabolic pathways in rheumatoid arthritis and osteoporosis toward drug repurposing
Zahra Ziaastani, Behjat Kalantari-Khandani, Mohammad-Javad Niazi, et al.
Computers in Biology and Medicine (2024) Vol. 180, pp. 108912-108912
Closed Access | Times Cited: 2
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis
Sara Turcinov, Ravi Sharma, Charlotte de Vries, et al.
RMD Open (2024) Vol. 10, Iss. 4, pp. e004510-e004510
Open Access | Times Cited: 2
Immune checkpoints in rheumatoid arthritis: progress and promise
Annabelle Small, Katie Lowe, Mihir D. Wechalekar
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer
Kaitlin R. McCarter, Senada Arabelovic, Xiaosong Wang, et al.
Seminars in Arthritis and Rheumatism (2023) Vol. 64, pp. 152335-152335
Closed Access | Times Cited: 5
Reinforcing the Checkpoint in Rheumatoid Arthritis
Ellen M. Gravallese, Ranjeny Thomas
New England Journal of Medicine (2023) Vol. 388, Iss. 20, pp. 1905-1907
Closed Access | Times Cited: 4
Use of antibiotics as a therapeutic approach to prevent AKI-to-CKD progression
Yu Kurata, Masaomi Nangaku
Kidney International (2023) Vol. 104, Iss. 3, pp. 418-420
Open Access | Times Cited: 4
The plethora of immunomodulatory drugs: opportunities for immune-mediated kidney diseases
Balazs Odler, Johanna Tieu, Katharina Artinger, et al.
Nephrology Dialysis Transplantation (2023) Vol. 38, Iss. Supplement_2, pp. ii19-ii28
Closed Access | Times Cited: 4
PD-1–PD-L1 immunomodulatory pathway regulates cardiac regeneration
Juan Qin, Guo N. Huang, Javid J. Moslehi
Nature Cardiovascular Research (2024) Vol. 3, Iss. 4, pp. 410-411
Closed Access | Times Cited: 1
Insufficient PD-1 expression during active autoimmune responses: a deep single-cell proteomics analysis in inflammatory arthritis
Eleni‐Kyriaki Vetsika, G. Fragoulis, Maria Kyriakidi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Injectable butyrate-prodrug micelles induce long-acting immune modulation and prevent autoimmune arthritis in mice
Shijie Cao, Erica Budina, Ruyi Wang, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 281-294
Closed Access | Times Cited: 1
Immune-Mediated Inflammatory Diseases and Cancer - a dangerous liaison
Jeanette A.M. Maier, Sara Castiglioni, Alessandra Petrelli, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Th Pathways in Immune-Mediated Skin Disorders: A Guide for Strategic Treatment Decisions
Reinhart Speeckaert, Arno Belpaire, Jo Lambert, et al.
Immune Network (2024) Vol. 24, Iss. 5
Open Access | Times Cited: 1
Insights into the Pathogenesis of Pyoderma Gangrenosum
Sarah Becker, Morgan Vague, Alex G. Ortega‐Loayza
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 1
Immune Checkpoints in Solid Organ Transplantation
Arnaud Del Bello, Emmanuel Treiner
Biology (2023) Vol. 12, Iss. 10, pp. 1358-1358
Open Access | Times Cited: 3
When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
Marino Paroli, Maria Isabella Sirinian
Antibodies (2023) Vol. 12, Iss. 4, pp. 69-69
Open Access | Times Cited: 3

Scroll to top